Martha Louise Garrity
Direktor/Vorstandsmitglied bei Orla Protein Technologies Ltd.
Profil
Martha Louise Garrity is a professional who currently holds a Non-Executive Director position at Orla Protein Technologies Ltd.
She previously worked as an Executive Director & Technical Director at Immunodiagnostic Systems Holdings Ltd.
from 2010 to 2013 and as a Chief Technical Officer at Immunodiagnostic Systems Nordic A.
Garrity has an undergraduate degree from the University of New Hampshire and a doctorate from The University of North Carolina at Charlotte.
Aktive Positionen von Martha Louise Garrity
| Unternehmen | Position | Beginn |
|---|---|---|
Orla Protein Technologies Ltd.
 Orla Protein Technologies Ltd. Medical SpecialtiesHealth Technology Orla Protein Technologies Ltd. manufactures protein products for use in cell culture, diagnostics and biosensors. Its products and services include recombinant proteins and antigens, proteins and surfaces for assay development, protein kits for analytical biochip and cell culture surfaces. The company was founded by Dale Athey and Jeremy Lakey on October 26, 2001 and is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Martha Louise Garrity
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 20.06.2013 |
Immunodiagnostic Systems Nordic A/S
 Immunodiagnostic Systems Nordic A/S Medical SpecialtiesHealth Technology Immunodiagnostic Systems Nordic A/S develops diagnostic testing kits for clinical and research markets. It offers its services in the field of diagnostics of bone and cartilage diseases such as osteoporosis, bone metastasis, arthritis, and osteoarthritis. The firm produces bone markers and cartilage markers, besides providing testing services. The company was founded on November 1, 1992 and is headquartered in Copenhagen, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Martha Louise Garrity
| University of New Hampshire | Undergraduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Immunodiagnostic Systems Holdings Ltd.
 Immunodiagnostic Systems Holdings Ltd. Medical SpecialtiesHealth Technology Immunodiagnostic Systems Holdings Plc engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. The company was founded in 1977 and is headquartered in Boldon, the United Kingdom. | Health Technology |
Immunodiagnostic Systems Nordic A/S
Immunodiagnostic Systems Nordic A/S Medical SpecialtiesHealth Technology Immunodiagnostic Systems Nordic A/S develops diagnostic testing kits for clinical and research markets. It offers its services in the field of diagnostics of bone and cartilage diseases such as osteoporosis, bone metastasis, arthritis, and osteoarthritis. The firm produces bone markers and cartilage markers, besides providing testing services. The company was founded on November 1, 1992 and is headquartered in Copenhagen, Denmark. | Health Technology |
Orla Protein Technologies Ltd.
Orla Protein Technologies Ltd. Medical SpecialtiesHealth Technology Orla Protein Technologies Ltd. manufactures protein products for use in cell culture, diagnostics and biosensors. Its products and services include recombinant proteins and antigens, proteins and surfaces for assay development, protein kits for analytical biochip and cell culture surfaces. The company was founded by Dale Athey and Jeremy Lakey on October 26, 2001 and is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Health Technology |
